BINA DAILY · 2026-09-26
Today: AI policy and product news, plus the latest in health and medicine.
|
BINA DAILY · 2026-09-26
|
|
AI BRIEF
AI Infrastructure, New Models, and Legal Reckoning: This Week in AI
Anthropic lands an $11.6B infrastructure deal, Claude Opus 5.5 launches, and rogue AI agents trigger legal scrutiny.
IN TODAY'S BRIEF
- Akamai Locks in $11.6 Billion Infrastructure Deal with Anthropic
- DeepSeek Crosses $1 Billion Annualized Revenue After API Price Hikes
- Microsoft Merges and Overhauls Copilot for the Workplace
- Anthropic Launches Claude Opus 5.5 with 40% Lower Running Cost
- OpenAI Broadens the GPT-6 Line with Sol and Luna
- Rogue AI Agents Trigger Legal Accountability Questions
Read the full AI brief →
|
|
|
HEALTH ROUNDUP
Flu Season Preparedness, Kidney Protection Breakthrough, and Europe's AMR Warning
WHO finalises the 2026–27 flu vaccine composition, a kidney trial halts early for benefit, and Europe's AMR report raises resistance alarms.
IN TODAY'S BRIEF
- Saturday, 26 September: WHO Finalises 2026–27 Northern Hemisphere Influenza Vaccine Composition
- Saturday, 26 September: Phase-3 Kidney Disease Trial Stopped Early for Sotagliflozin Benefit
- Friday, 25 September: ECDC and WHO Warn of 14% Rise in Carbapenem-Resistant Bloodstream Infections
- Friday, 25 September: Oral NMDA Modulator Shows Promise in Treatment-Resistant Depression
- Friday, 25 September: USPSTF Lowers Colorectal Cancer Screening Start Age to 40
- Thursday, 24 September: ECDC Issues Late-Season Heat Advisory for Southern Mediterranean, Including Cyprus
- Thursday, 24 September: Four-Month MDR-Tuberculosis Regimen Non-Inferior to Standard Six-Month Course
Read the full health roundup →
|
